Cargando…

Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB?

BACKGROUND: Maintaining urinary continence is not an automatic process, but relies on continuous processing of sensory signals from the bladder and suppression of the desire to void. Urinary incontinence (UI) and lower urinary tract symptoms (LUTS), including urinary urgency, frequency, and nocturia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibson, William, Makhani, Asad, Hunter, Kathleen F., Wagg, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Canadian Geriatrics Society 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704076/ https://www.ncbi.nlm.nih.gov/pubmed/33282051 http://dx.doi.org/10.5770/cgj.23.423

Ejemplares similares

Do we need more patient‐friendly treatment options for overactive bladder (OAB)?
por: Gerig, Nel, et al.
Publicado: (2021)

Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
por: Makhani, Asad, et al.
Publicado: (2020)

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
por: Frankel, Jeffrey, et al.
Publicado: (2023)

Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review
por: Khizer, Zara, et al.
Publicado: (2021)

Urinary urgency acts as a source of divided attention leading to changes in gait in older adults with overactive bladder
por: Gibson, William, et al.
Publicado: (2021)

The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population
por: Lai, H. Henry, et al.
Publicado: (2016)

Psychometric Properties of the Korean Version of the Overactive Bladder Questionnaire (OAB-q) in a Korean Population
por: Oh, Seung-June, et al.
Publicado: (2012)

Personalised 3D-Printed Mucoadhesive Gastroretentive Hydrophilic Matrices for Managing Overactive Bladder (OAB)
por: Khizer, Zara, et al.
Publicado: (2023)

Selective bladder denervation for overactive bladder (OAB) syndrome: From concept to healing outcomes using the ovine model
por: Fugett, James, et al.
Publicado: (2018)

Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
por: Desroziers, Katia, et al.
Publicado: (2013)

Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management
por: Turell, Wendy, et al.
Publicado: (2020)

Overactive bladder: strategies to ensure treatment compliance and adherence
por: Dhaliwal, Prabhpreet, et al.
Publicado: (2016)

Mirabegron in the Management of Overactive Bladder Syndrome
por: O’Kane, Miriam, et al.
Publicado: (2022)

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
por: Yeowell, Gillian, et al.
Publicado: (2018)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Ulahannan, Danny, et al.
Publicado: (2009)

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder
por: Heesakkers, John, et al.
Publicado: (2022)

Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?
por: Morris, Vikky, et al.
Publicado: (2014)

An examination of the relationship between satisfaction with overactive bladder (OAB) treatment and the doctor–patient gender: A questionnaire‐based single‐institution study
por: Kouchi, Yukiko, et al.
Publicado: (2023)

OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study
por: Arribillaga, Leandro Cristian, et al.
Publicado: (2018)

AB316. SPR-43 Comparison of bladder volumes between 2D and 3D ultrasound calculations and urodynamic measurements in women with overactive bladder (OAB)
por: Bernardo, Rachel J., et al.
Publicado: (2016)

Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder
por: Wagg, Adrian
Publicado: (2012)

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions
por: Milsom, Ian, et al.
Publicado: (2020)

The Association Between Overactive Bladder and Falls and Fractures: A Systematic Review
por: Szabo, Shelagh M., et al.
Publicado: (2018)

Development of a core set of outcome measures for OAB treatment
por: Foust-Wright, Caroline, et al.
Publicado: (2017)

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK
por: Nazir, Jameel, et al.
Publicado: (2017)

Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data
por: Wagg, Adrian, et al.
Publicado: (2016)

Outcome reporting in randomized controlled trials (RCTs) on the pharmacological management of idiopathic overactive bladder (OAB) in women; a systematic review for the development of core outcome sets (COS)
por: Moussa, Reem, et al.
Publicado: (2022)

Influence of current state of executive function and working memory on adherence to antimuscarinic therapy in older women with OAB
por: Kosilov, Kirill, et al.
Publicado: (2019)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

AB33. Botox: the novel therapy for OAB
por: Deng, Donna
Publicado: (2014)

What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine
por: Wagg, Adrian S., et al.
Publicado: (2021)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
por: Shaw, Christina, et al.
Publicado: (2023)

Urine Proteomic Study in OAB Patients—Preliminary Report
por: Futyma, Konrad, et al.
Publicado: (2020)

The emperor has no clothes: OAB can be cured surgically
por: Petros, Peter
Publicado: (2022)

Comparison of vascularization and overall perfusion of the bladder wall between women with and without overactive bladder syndrome
por: Hsiao, Sheng-Mou, et al.
Publicado: (2020)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bpng8vfcdl52365k12i37lnolu